3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 25g

3-((tert-Butoxycarbonyl)amino)-4-chlorobenzoic acid, 97%, 10g

2-Chloro-4-(methylamino)pyrimidine-5-carbaldehyde, 95.0%, 1g

2-Fluoro-3-(trifluoromethyl)benzyl bromide, 98.0%, 250mg

methyl 5-iodo-1H-pyrazole-4-carboxylate, 95%, 250mg

1-(Boc-amino)-(pyrrolidin-3-yl)-cyclopropane, 97.0%, 10g

3-(3-Fluorophenyl)-2,2-dimethylpropanoic acid, 1g

2-(4,4-difluoropiperidin-1-yl)ethan-1-ol hydrochloride, 95.0%, 500mg

Tripropylene glycol monobutyl ether, min 95%, for synthesis, 1L, plastic packaging.

2-(3-Oxocyclohexyl)acetic acid, 97%, 100mg

2-Chloro-1-[4-(2-fluoro-phenyl)-piperazin-1-yl]-ethanone, 95.0%, 5g

1,5,7-Triazabicyclo[4.4.0]dec-5-ene>98.0%(HPLC)(T)5g

Methyl N-Acetyl-L-isoleucine, 95.0%, 1g